RecallDepth
Class II Terminated

Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56

Company
Teva Pharmaceuticals Usa
Recall Initiated
February 7, 2017
Posted
March 22, 2017
Recall Number
D-0517-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7,628 HDPE bottles (228,840 tablets)
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide

Lot / Code Info

Lot 30227056A; Exp. 03/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls